Journal of Medicinal Chemistry, volume 66, issue 16, pages 11250-11270

Rational Design and Development of Selective BRD7 Bromodomain Inhibitors and Their Activity in Prostate Cancer

Sandra C Ordonez Rubiano ¹

Chad A Maschinot ¹

Sijie Wang ¹

Surbhi Sood ¹

Luisa F. Baracaldo-Lancheros ¹

Brayden P Strohmier ¹

Alexander J. McQuade ¹

Brian C. Smith ²

Emily C Dykhuizen ^{1, 3}

Show full list: 9 authors

Hide authors affiliations

Department of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University. Robert Heine Pharmacy Building 575 Stadium Mall Drive, West Lafayette, Indiana 47907, United States |

Department of Biochemistry, Program in Chemical Biology, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, United States |

Purdue Center for Cancer Research, College of Pharmacy, Purdue University, 201 S University St., West Lafayette, Indiana 47907, United States |

Publication type: Journal Article

Publication date: 2023-08-08

American Chemical Society (ACS)

Journal: Journal of Medicinal Chemistry

scimago Q1

wos Q1

SJR: 1.986

CiteScore: 12.8

Impact factor: 6.8

ISSN: 00222623, 15204804

DOI: 10.1021/acs.jmedchem.3c00671

Copy DOI

Drug Discovery

Molecular Medicine

Found

	1 2
Signal Transduction and Targeted Therapy	Signal Transduction and Targeted Therapy, 2, 25% Signal Transduction and Targeted Therapy 2 publications, 25%
Frontiers in Epigenetics and Epigenomics	Frontiers in Epigenetics and Epigenomics, 1, 12.5% Frontiers in Epigenetics and Epigenomics 1 publication, 12.5%
Epigenomes	Epigenomes, 1, 12.5% Epigenomes 1 publication, 12.5%
Nature Reviews Drug Discovery	Nature Reviews Drug Discovery, 1, 12.5% Nature Reviews Drug Discovery 1 publication, 12.5%
Cell Reports	Cell Reports, 1, 12.5% Cell Reports 1 publication, 12.5%
Journal of Cellular and Molecular Medicine	Journal of Cellular and Molecular Medicine, 1, 12.5% Journal of Cellular and Molecular Medicine 1 publication, 12.5%
	1 2

	1 2 3
Springer Nature	Springer Nature, 3, 37.5% Springer Nature 3 publications, 37.5%
Frontiers Media S.A.	Frontiers Media S.A., 1, 12.5% Frontiers Media S.A. 1 publication, 12.5%
Cold Spring Harbor Laboratory	Cold Spring Harbor Laboratory, 1, 12.5% Cold Spring Harbor Laboratory 1 publication, 12.5%
MDPI	MDPI, 1, 12.5% MDPI 1 publication, 12.5%
Elsevier	Elsevier, 1, 12.5% Elsevier 1 publication, 12.5%
Wiley	Wiley, 1, 12.5% Wiley 1 publication, 12.5%
	1 2 3

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.

Metrics

Cite this

GOST | RIS | BibTex | MLA

Found error?

Publisher

American Chemical Society (ACS)

Journal

Journal of Medicinal Chemistry

scimago Q1

wos Q1

SJR

1.986

CiteScore

12.8

Impact factor

6.8

ISSN

00222623 (Print)

15204804 (Electronic)

Rational Design and Development of Selective BRD7 Bromodomain Inhibitors and Their Activity in Prostate Cancer

Top-30

Journals

Publishers

Are you a researcher?